| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
Institute of Neurochemistry, 71 Rådmandsgade, DK-2200 Copenhagen N [J. C.], and Department of Nuclear Medicine, Rigshospitalet, 9 Blegdamsvej, DK-2100 Copenhagen Ø [C. J. E., J. F.], Denmark
67Ga is known to concentrate in a variety of malignant tumors. Immunoelectrophoresis combined with autoradiography of human serum incubated with 67Ga showed that the radionuclide is associated with transferrin, apart from a weak binding to ß-lipoprotein. The thermodynamic constant for gallium was estimated and indicated that gallium citrate in the presence of serum proteins occurred in a colloid form bound to transferrin.
Ultracentrifugation of tumor homogenates obtained from patients who had received i.v. injections of 67Ga citrate for scintigraphy demonstrated that 67Ga is preferentially bound to proteins in the nuclei fraction. Acrylamide gel electrophoresis of extracts of cancer tissue indicated that intracellular 67Ga is associated mainly with a fast-migrating substance, perhaps a protein, with a molecular weight lower than that of ferritin.
Received 7/13/73. Accepted 4/ 2/74.
This article has been cited by other articles:
![]() |
Z. M. Qian, H. Li, H. Sun, and K. Ho Targeted Drug Delivery via the Transferrin Receptor-Mediated Endocytosis Pathway Pharmacol. Rev., December 1, 2002; 54(4): 561 - 587. [Abstract] [Full Text] [PDF] |
||||
![]() |
L. R. Bernstein Mechanisms of Therapeutic Activity for Gallium Pharmacol. Rev., December 1, 1998; 50(4): 665 - 682. [Abstract] [Full Text] [PDF] |
||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
| Cancer Research | Clinical Cancer Research |
| Cancer Epidemiology Biomarkers & Prevention | Molecular Cancer Therapeutics |
| Molecular Cancer Research | Cancer Prevention Research |
| Cancer Prevention Journals Portal | Cancer Reviews Online |
| Annual Meeting Education Book | Meeting Abstracts Online |